Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Acute Pain in Traumatic Injury
NCT03928015Phase 2Withdrawn
- Sponsor
- CommonSpirit Health
- Start
- Oct 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in acute pain, sponsored by CommonSpirit Health. Planned start Oct 2019; status: withdrawn.
02
Drugs
dronabinol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03928015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928015.